ac8 vs cann

Can anyone justify to me why the Cann Group MC is 80M dollars more then AC8?

I am quite well caught up on the medical marijuana space, and to my understanding both these companies are at the forefront of marijuana in Australia. Both are very far progressed into acquiring all the necessary licence either operate themselves in Australia or operate through a subsidiary they own (see Tasmanian alkaloids). My personal view sees ac8 as a more valuable company and is closer to generating revenues then what CANN is, yet this is not shown through MC.

Willing to take a position in either of these companies, but not both and want to get some info from current investors?